Clinical Trial Update: Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability of candesartan cilexetil under fasting conditions. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED